Aprendiendo sobre anticoagulación con la COVID-19

FU L, WANG B, YUAN T, CHEN X, AO Y, FITZPATRICK T et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis. J Infect 2020; 80: 656-665. https:doi.org10.1016/j.jinf.2020.03.041

TERPOS E, NTANASIS-STATHOPOULOS I, ELALAMY I, KASTRITIS E, SERGENTANIS TN, POLITOU M et al. Hematological findings and complications of COVID-19. Am J Hematol 2020; 95: 834-847. https://doi.org/10.1002/ajh.25829

SHAH A, DONOVAN K, MCHUGH A, PANDEY M, AARON L, BRADBURY CA et al. Thrombotic and haemorrhagic complications in critically ill patients with COVID-19: a multicentre observational study. Crit Care 2020; 24: 561. https://doi.org/10.1186/s13054-020-03260-3

KLOK FA, KRUIP M, VAN DER MEER NJM, ARBOUS MS, GOMMERS D, KANT KM et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 2020; 191: 145-147. https://doi.org/10.1016/j.thromres.2020.04.013

AL-SAMKARI H, KARP LEAF RS, DZIK WH, CARLSON JCT, FOGERTY AE, WAHEED A et al. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood 2020; 136: 489-500. https://doi.org/10.1182/blood.2020006520

ÁLVAREZ-RODRÍGUEZ E, GONZÁLEZ GONZÁLEZ R, TORRES-GÁRATE R, LÓPEZ RIQUELME P, GONZÁLEZ MARTIL I, ABAD CUÑADO V. Aprendiendo con el COVID-19: ¿qué pasa con la anticoagulación? An Sist Sanit Navar 2020; 43: 251-254. https:doi.org10.23938/ASSN.0884

MOORES LK, TRITSCHLER T, BROSNAHAN S, CARRIER M, COLLEN JF, DOERSCHUG K et al. Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019: CHEST guideline and expert panel report. Chest 2020; 158: 1143-1163. https://doi.org/10.1016/j.chest.2020.05.559

SPYROPOULOS AC, LEVY JH, AGENO W, CONNORS JM, HUNT BJ, IBA T et al. Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost 2020; 18: 1859-1865. https://doi.org/10.1111/jth.14929

National Institutes of Health (NIH). News and events (December 22, 2020). ACTIV Trial of blood thinners pauses enrollment of critically ill COVID-19 patients. https://www.nih.gov/news-events/news-releases/nih-activ-trial-blood-thinners-pauses-enrollment-critically-ill-covid-19-patients.